| 000 | 01371 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516220406.0 | ||
| 264 | 0 | _c20150416 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1744-8409 | ||
| 024 | 7 |
_a10.1586/1744666X.2014.929943 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVella, Laura J | |
| 245 | 0 | 0 |
_aImmune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment. _h[electronic resource] |
| 260 |
_bExpert review of clinical immunology _cAug 2014 |
||
| 300 |
_a1107-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 700 | 1 | _aAndrews, Miles C | |
| 700 | 1 | _aBehren, Andreas | |
| 700 | 1 | _aCebon, Jonathan | |
| 700 | 1 | _aWoods, Katherine | |
| 773 | 0 |
_tExpert review of clinical immunology _gvol. 10 _gno. 8 _gp. 1107-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/1744666X.2014.929943 _zAvailable from publisher's website |
| 999 |
_c23928735 _d23928735 |
||